New data, published in JMIR, demonstrates the value of personalized messaging encouraging flu vaccinations in Dario members with diabetes
DarioHealth Corp., a leader in the global digital health market, announced new research published in the Journal of Medical Internet Research demonstrating the effectiveness of personalized digital health interventions to drive flu vaccine awareness in Dario members living with diabetes.
People living with diabetes are at risk of severe complications from the flu, yet low awareness keeps many from receiving an influenza vaccination. To better understand how digital health tools could raise awareness and improve vaccination rates in this population a pragmatic randomized follow-up study was performed using Dario’s digital health solution for diabetes management which delivers a highly personalized, whole health approach to help members improve overall health and outcomes. The study also aimed to highlight the effectiveness of personalizing digital interventions to positively impact member engagement and behavior change.
Health Technology Insights: Northwell Health completes merger with Nuvance Health
A previous randomized controlled study proved the effectiveness of a nudge intervention to improve vaccination rates, and Dario’s study’s was designed as a pragmatic follow-up to translate the initial insights into a real-world setting. To accomplish this, the research team leveraged Dario’s capabilities around personalization to deliver tailored messaging across a large data set of 64,904 members segmented into three groups: first, a group of members with exposure to a monthly flu vaccination campaign previously proven to impact vaccination rates; second, a group of members receiving an adapted version of the same campaign with more personalized and frequent messages; and third, a control group with no exposure to flu vaccination messages.
The results showcase the power of personalized digital health interventions with the second group demonstrating significantly improved awareness of the risks associated with the flu and higher rates of vaccination than the group receiving the messages previously tested in the RCT.
“At Dario, we’re constantly striving to deepen member engagement through personalized, meaningful interventions that drive real outcomes,” said Yifat Hershcovitz, PhD, Vice President of Clinical and Scientific Affairs at Dario. “This study highlights how our personalization engine can deliver measurable clinical impact. By helping members better understand their health and take action, such as avoiding severe flu-related complications, we believe that Dario is able to improve both individual well-being and client outcomes.”
Health Technology Insights: Knight Therapeutics Announces Relaunch of ONICIT in Brazil and Mexico
“Digital health creates powerful opportunities to engage people and change behaviors in meaningful ways. This study adds to the growing body of evidence showing how solutions like Dario can drive real clinical outcomes,” said Omar Manejwala, M.D., Chief Medical Officer at Dario. “We believe deeply in the power of personalization to improve health, and we’re proud to have our work featured in JMIR—a recognition of the science behind Dario’s approach to transforming care through digital innovation.”
Health Technology Insights: Crown Bioscience Achieves Green Lab Sustainability Certification
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
